XTRA:SRT3Life Sciences
Assessing Sartorius (XTRA:SRT3) Valuation As Viral Vaccine Media Demand Gains Attention
Why the viral vaccine media outlook matters for Sartorius
Fresh analysis pointing to rising demand for viral vaccine cell culture media, supported by more vaccine launches and public funding, puts Sartorius (XTRA:SRT3) back in focus for investors tracking bioprocess suppliers.
See our latest analysis for Sartorius.
At a share price of €221.1, Sartorius has a 1 day share price return of 3.03%, a 30 day share price return of 7.72% and a 90 day share price return of 12.26%. The 3 year total...